184 related articles for article (PubMed ID: 36806647)
21. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
Yook HJ; Lee JH
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
[TBL] [Abstract][Full Text] [Related]
22. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis.
Janmohamed SR; Gwillim EC; Yousaf M; Patel KR; Silverberg JI
Arch Dermatol Res; 2021 Oct; 313(8):669-677. PubMed ID: 33108524
[TBL] [Abstract][Full Text] [Related]
23. Association between Prurigo Nodularis and Etiologies of Peripheral Neuropathy: Suggesting a Role for Neural Dysregulation in Pathogenesis.
Hughes JM; Woo TE; Belzberg M; Khanna R; Williams KA; Kwatra MM; Hassan S; Kwatra SG
Medicines (Basel); 2020 Jan; 7(1):. PubMed ID: 31936197
[No Abstract] [Full Text] [Related]
24. Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis.
Kwon CD; Khanna R; Williams KA; Kwatra MM; Kwatra SG
Medicines (Basel); 2019 Sep; 6(4):. PubMed ID: 31561504
[TBL] [Abstract][Full Text] [Related]
25. Skin Microbiome in Prurigo Nodularis.
Tutka K; Żychowska M; Żaczek A; Maternia-Dudzik K; Pawełczyk J; Strapagiel D; Lach J; Reich A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108838
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab.
Deng J; Liao V; Parthasarathy V; Cornman HL; Kambala A; Kwatra MM; Ständer S; Piketty C; Chaskar P; Krishnaswamy JK; Julia V; Kwatra SG
JAMA Dermatol; 2023 Sep; 159(9):977-985. PubMed ID: 37556125
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: A multicenter cohort study.
Cornman HL; Deng J; Kambala A; Parthasarathy V; Reddy SV; Kwatra SG
JAAD Int; 2023 Dec; 13():74-82. PubMed ID: 37711338
[TBL] [Abstract][Full Text] [Related]
28. Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
Kimel M; Zeidler C; Kwon P; Revicki D; Ständer S
JAMA Dermatol; 2020 Dec; 156(12):1354-1358. PubMed ID: 32936233
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.
Ständer S; Ketz M; Kossack N; Akumo D; Pignot M; Gabriel S; Chavda R
Acta Derm Venereol; 2020 Nov; 100(18):adv00309. PubMed ID: 33021323
[TBL] [Abstract][Full Text] [Related]
30. RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching.
Shao Y; Zhu Y; Xiao Z; Shen Y; Dai B; Tang H; Wang D
Exp Dermatol; 2023 Jan; 32(1):30-40. PubMed ID: 36134503
[TBL] [Abstract][Full Text] [Related]
31. Association of prurigo nodularis and lichen simplex chronicus with hospitalization for mental health disorders in US adults.
Singam V; Patel KR; Silverberg JI
Arch Dermatol Res; 2020 Oct; 312(8):587-593. PubMed ID: 32078024
[TBL] [Abstract][Full Text] [Related]
32. A critical evaluation of nemolizumab for prurigo nodularis.
Brooks SG; Yosipovitch G
Expert Rev Clin Immunol; 2024 Jun; 20(6):577-587. PubMed ID: 38217530
[TBL] [Abstract][Full Text] [Related]
33. Abnormal Plasma Levels of Steroids and Their Ratios in Patients With Prurigo Nodularis: A Pilot Study.
Chu L; Shu X; Wu Y; Yang H; Lu Q; Deng H
Front Physiol; 2022; 13():835269. PubMed ID: 35837010
[No Abstract] [Full Text] [Related]
34. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
Serra-Baldrich E; Santamaría-Babí LF; Francisco Silvestre J
Actas Dermosifiliogr; 2022; 113(7):674-684. PubMed ID: 35842249
[TBL] [Abstract][Full Text] [Related]
35. Serotonin and interleukin-6: Association with pruritus severity, sleep quality and depression severity in Prurigo Nodularis.
Konda D; Chandrashekar L; Rajappa M; Kattimani S; Thappa DM; Ananthanarayanan PH
Asian J Psychiatr; 2015 Oct; 17():24-8. PubMed ID: 26277226
[TBL] [Abstract][Full Text] [Related]
36. Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
Ma F; Gharaee-Kermani M; Tsoi LC; Plazyo O; Chaskar P; Harms P; Patrick MT; Xing X; Hile G; Piketty C; Lazzari A; Van Delm W; Maverakis E; Nakamura M; Modlin RL; Kahlenberg JM; Billi AC; Julia V; Krishnaswamy JK; Gudjonsson JE
J Allergy Clin Immunol; 2024 Jan; 153(1):146-160. PubMed ID: 37506977
[TBL] [Abstract][Full Text] [Related]
37. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
Pereira MP; Basta S; Moore J; Ständer S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
[TBL] [Abstract][Full Text] [Related]
38. The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.
Ständer S; Fofana F; Dias-Barbosa C; Rodriguez D; Budhiarso I; Jabbar-Lopez ZK; Piketty C; Vernon M; Puelles J
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1587-1602. PubMed ID: 37329468
[TBL] [Abstract][Full Text] [Related]
39. Prurigo nodularis comparative treatment outcome in patients attending a tertiary hospital in northern Tanzania.
Mayala EV; Mavura DR; Robert M; Masenga EJ
Dermatol Ther; 2021 Mar; 34(2):e14855. PubMed ID: 33559259
[TBL] [Abstract][Full Text] [Related]
40. Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment.
Gründel S; Pereira MP; Storck M; Osada N; Schneider G; Ständer S; Zeidler C
Acta Derm Venereol; 2020 Sep; 100(16):adv00269. PubMed ID: 32556359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
